In addition, target genes of several compounds that were recently shown to be able to enhance tumor response to anti-PD1 are also on the top list of our association prediction (Supplementary Data 1a), such as inhibitors of the encoded proteins of GSK3B, CDK4, and PTK2. In particular, several very recent studies also cross-validated our prediction. The gene discussed is CDK4; the disease is neoplasm.